Last $0.29 USD
Change Today 0.00 / 0.00%
Volume 0.0
RVALL On Other Exchanges
Symbol
Exchange
Frankfurt
OTC US
As of 4:30 PM 12/12/14 All times are local (Market data is delayed by at least 15 minutes).

reva medical inc - cdi (RVALL) Key Developments

REVA Medical, Inc. Reports Unaudited Consolidated Earnings Results for the Fourth Quarter and Year Ended December 31, 2014

REVA Medical, Inc. reported unaudited consolidated earnings results for the fourth quarter and year ended December 31, 2014. For the quarter, the company's loss from operations was $5,413,000 compared to $7,752,000 for the same period of last year. Net loss was $39,309,000 compared to $7,753,000 for the same period of last year. Net loss per share, basic and diluted was $1.18 compared to $0.23 for the same period of last year. For the year, the company's loss from operations was $21,963,000 compared to $27,943,000 for the same period of last year. Loss attributable to members was $55,815,000 compared to $27,922,000 for the same period of last year. Net loss per share, basic and diluted was $1.67 compared to $0.84 for the same period of last year. Net cash used for operating activities was $17,930,000 compared to $21,943,000 for the same period of last year. Purchases of property and equipment were $541,000 compared to $1,466,000 for the same period of last year.

REVA Medical, Inc. Appoints Dr. Ross Breckenridge to the Board

REVA Medical, Inc. announced that Dr. Ross Breckenridge appointed to its Board as a non-executive director. Dr. Breckenridge currently serves on the boards of Senrigan Capital, Empower India, and the Cornelia de Lange Society of Great Britain.

REVA Medical, Inc. Presents at 33rd Annual J.P. Morgan Healthcare Conference, Jan-15-2015 11:30 AM

REVA Medical, Inc. Presents at 33rd Annual J.P. Morgan Healthcare Conference, Jan-15-2015 11:30 AM. Venue: Westin St. Francis Hotel, San Francisco, California, United States. Speakers: Robert B. Stockman, Co-founder, Chairman and Chief Executive Officer.

REVA Medical, Inc. Announces Auditors Changes

REVA Medical, Inc. advised that it has appointed Grant Thornton LLP as the company's independent registered public accounting firm for its fiscal year ending December 31, 2014. Grant Thornton replaces Ernst & Young LLP in this capacity and the appointment is effective December 19, 2014.

REVA Medical, Inc. Announces Change in Registered Office Address

­REVA Medical, Inc. has changed its Australian registered office address to c/o Buchan Pty. Ltd., Suite 4, Level 14, 6 O'Connell Street, Sydney, NSW 2000. The company's US registered office address remains unchanged. The company has also changed its local agent from Inteq Limited to Buchan with effect from December 5, 2014.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
RVALL:US $0.29 USD 0.00

RVALL Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for RVALL.
View Industry Companies
 

Industry Analysis

RVALL

Industry Average

Valuation RVALL Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact REVA MEDICAL INC - CDI, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.